News | April 29, 2015

IBA, Pravida to Collaborate on Single-Room Proton Therapy in Europe

Agreement will integrate IBA’s compact Proteus One system with Pravida’s turnkey radiation protection facilities

IBA, Pravida Bau, single-room proton therapy, Europe

April 29, 2015 — Ion Beam Applications S.A. (IBA) and Pravida Bau GmBH announced an agreement to supply integrated single-room proton therapy solutions to customers in Europe.

The solution will combine Proteus One, IBA’s compact proton therapy system, with the patented Forster – Sandwich – Construction method exclusively installed by Pravida Bau, which designs and builds turnkey radiation protection facilities. This construction method is fast and easy to install and reduces the environmental footprint of the project through the use of local material filling, rather than overreliance on concrete.

Of the 34 proton therapy centers ordered to IBA, seven have chosen for Proteus One, IBA’s compact single-room proton therapy solution that can be integrated easily into many kinds of healthcare settings. The combination of smaller system size, strong clinical capabilities and patient-centered design of ProteusONE makes proton therapy more accessible to clinical institutions and their patients worldwide.

The system delivers intensity modulated proton therapy (IMPT), which combines the precise dose delivery of pencil beam scanning (PBS) with the dimensionally accurate imaging of 3-D cone beam computed tomography (CBCT), enabling physicians to truly track where protons will be targeting tumor cells.

For more information:

Related Content

MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...